Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-24-000070
Filing Date
2024-08-06
Accepted
2024-08-06 16:52:22
Documents
1
Period of Report
2024-08-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3426
  Complete submission text file 0001765581-24-000070.txt   4976
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address
Mulligan Seamus (Reporting) CIK: 0001536639 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 241180189